This study demonstrates the successful isolation of CNS-derived sEVs from human saliva, establishing them as a viable platform for AD biomarker detection, cognitive monitoring, and neuroinflammatory profiling.

Next Steps: Future studies will validate the diagnostic utility of these sEV biomarkers in clinical cohorts comparing AD subjects against healthy controls and leverage multi-omics approaches to fully characterize the complex sEV cargo.